Alfresa HoldingsALFRY 75 Operating Margin % is 0.87% as of Mar. 2026, which is 33% below its 10-year median of 1.30. GuruFocus rates ALFRY with a GF Score™ of 75/100 and a GF Value™ of $16.31 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 117 Medical Distribution companies, Alfresa Holdings ranks worse than 70.94% on this metric.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Alfresa Holdings Operating Margin % Related Terms
Alfresa Holdings Operating Margin % Historical Data
* Premium members only.
The historical data trend for Alfresa Holdings's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ALFRY vs MCK, CAH, COR: Operating Margin % Comparison
For the Medical Distribution subindustry, Alfresa Holdings's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alfresa Holdings Operating Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Alfresa Holdings's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Alfresa Holdings's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alfresa Holdings (ALFRY) has a Operating Margin % of 0.87% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Alfresa Holdings and its competitors. This is 33% below median its historical median of 1.30. Over the past decade, Alfresa Holdings' Operating Margin % has ranged from 1.07 to 1.77. According to the industry distribution chart, Alfresa Holdings ranks #83 out of 117 companies in the Medical Distribution industry, placing it in the top 70.9%.
Is Alfresa Holdings' Operating Margin % too high?
Alfresa Holdings' current Operating Margin % of 0.87% is 33% below median its 10-year median of 1.30. Over the past 10 years, this metric has ranged from a low of 1.07 to a high of 1.77. The Medical Distribution industry median Operating Margin % is 3.05. Alfresa Holdings' value of 0.87% is 71.5% below this industry median. Based on the distribution chart, Alfresa Holdings ranks #83 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Alfresa Holdings has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' Operating Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Alfresa Holdings ranks #83 out of 117 companies for Operating Margin %. This places Alfresa Holdings in the lower half of its industry. The industry median Operating Margin % is 3.05. Alfresa Holdings' value of 0.87% is 71.5% below this benchmark. Historically, Alfresa Holdings' own Operating Margin % has ranged from 1.07 to 1.77 over the past decade. While the company's 10-year median is 1.30 vs. the industry median of 3.05, Alfresa Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Distribution company?
The median Operating Margin % among Medical Distribution companies is 3.05, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alfresa Holdings's current Operating Margin % of 0.87% is 71.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Alfresa Holdings and its competitors. For the Medical Distribution industry, the median Operating Margin % is 3.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alfresa Holdings's current Operating Margin % is 0.87%, which is 33% below median its own 10-year median of 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (ALFRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.31, compared to a current price of $13.80 — trading 15.4% below its estimated fair value. The current Operating Margin % is 0.87%, which is 33% below median its 10-year median of 1.30 and 71.5% below the Medical Distribution industry median of 3.05. Alfresa Holdings' overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Alfresa Holdings (ALFRY), the current Operating Margin % is 0.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alfresa Holdings (ALFRY) Overvalued in 2026?
Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued.
The current stock price of $13.80 is trading 15.4% below its estimated GF Value™ of $16.31.
GuruFocus considers Alfresa Holdings to be Modestly Undervalued.
Key valuation signals for ALFRY:
Operating Margin %: 0.87% (33% below median its 10-year median of 1.30)
GF Value™: $16.31 vs. price of $13.80 (15.4% below fair value)
Industry Position: 71.5% below the Medical Distribution median (#83 of 117)
No single metric tells the full story. See the ALFRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
75GF Score
Get the complete analysis for ALFRY
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALFRY has been successfully added to your 
